By physician referral or invitation only

Time In Glucose Hospital Target- TIGHT A randomized clinical trial to evaluate the use of CGM to achieve a mean glucose target of 90 to 130 mg/dL without hypoglycemia in hospitalized adults with type 2 diabetes

The study is being done in hospitalized people with diabetes. The purpose is to see if a near normal glucose (sometimes referred to as blood sugar) range can be safely achieved with use of continuous glucose monitoring (CGM).

Age & Gender

18 years ~ 99 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

North Carolina (Statewide)

Additional Study Information

Principal Investigator

Morgan Jones
Medicine-Endocrinology

Study Type

Clinical or Medical
Interventional

Study Topics

Diabetes
Obesity

IRB Number

21-3316

ClinicalTrials.gov

NCT05135676

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.